Unique strategy restores p53 function in mice.
Bucci
Mirella
M
D000256:Adenoviridae; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D017353:Gene Deletion; D015696:Gene Products, tat / Q000494:pharmacology; D016158:Genes, p53 / Q000187:drug effects*; D006801:Humans; D051379:Mice; D009154:Mutation; D015514:Oncogene Proteins, Fusion / Q000494:pharmacology; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000502:physiology*; D014765:Viral Vaccines / Q000494:pharmacology
D000970:Antineoplastic Agents; D015696:Gene Products, tat; D015514:Oncogene Proteins, Fusion; D016159:Tumor Suppressor Protein p53; D014765:Viral Vaccines; C464532:dl1520